LIPOCINE INC. (LPCN) Scorecard
- 2026-Q2: Total return Lose; Revenue growth Lose; EPS growth Lose.
- 2026-Q1: Total return Win; Revenue growth Lose; EPS growth Lose.
- 2025-Q4: Total return Win; Revenue growth Lose; EPS growth Lose.
- 2025-Q3: Total return Lose; Revenue growth Lose; EPS growth Lose.
26/120
All 120 Win/Lose results shown below
Every strict quarterly win earns 1 point. A loss, tie, or unavailable scoring value earns 0.
Trailing 1 year (4 quarters): 2 wins, 10 lossesLast fetched: 4 Sept 2026
Complete point ledger
Each cell identifies the missing side explicitly.
| Quarter | Total return | Revenue growth | EPS growth |
|---|---|---|---|
| 2026-Q20/3 |
LoseLPCN / S&P -67.96% / 15.20% |
LoseLPCN / S&P LPCN unavailable / 15.00% |
LoseLPCN / S&P LPCN unavailable / 50.40% |
| 2026-Q11/3 |
WinLPCN / S&P -0.50% / -4.33% |
LoseLPCN / S&P LPCN unavailable / 11.30% |
LoseLPCN / S&P LPCN unavailable / 27.70% |
| 2025-Q41/3 |
WinLPCN / S&P 181.75% / 2.65% |
LoseLPCN / S&P LPCN unavailable / 9.00% |
LoseLPCN / S&P LPCN unavailable / 13.40% |
| 2025-Q30/3 |
LoseLPCN / S&P -9.81% / 8.12% |
LoseLPCN / S&P LPCN unavailable / 4.61% |
LoseLPCN / S&P LPCN unavailable / 13.45% |
| 2025-Q20/3 |
LoseLPCN / S&P -0.63% / 10.94% |
LoseLPCN / S&P LPCN unavailable / 4.83% |
LoseLPCN / S&P LPCN unavailable / 10.63% |
| 2025-Q10/3 |
LoseLPCN / S&P -34.84% / -4.27% |
LoseLPCN / S&P LPCN unavailable / 4.98% |
LoseLPCN / S&P LPCN unavailable / 10.57% |
| 2024-Q41/3 |
WinLPCN / S&P 8.69% / 2.41% |
LoseLPCN / S&P LPCN unavailable / 5.25% |
LoseLPCN / S&P LPCN unavailable / 6.15% |
| 2024-Q30/3 |
LoseLPCN / S&P -45.51% / 5.89% |
LoseLPCN / S&P LPCN unavailable / 5.89% |
LoseLPCN / S&P -75.80% / 6.11% |
| 2024-Q21/3 |
WinLPCN / S&P 58.46% / 4.28% |
LoseLPCN / S&P LPCN unavailable / 5.38% |
LoseLPCN / S&P -33.47% / 5.12% |
| 2024-Q11/3 |
WinLPCN / S&P 86.38% / 10.56% |
LoseLPCN / S&P LPCN unavailable / 5.71% |
LoseLPCN / S&P -26.29% / 5.59% |
| 2023-Q41/3 |
LoseLPCN / S&P -6.38% / 11.69% |
LoseLPCN / S&P LPCN unavailable / 6.81% |
WinLPCN / S&P 95.63% / 7.78% |
| 2023-Q31/3 |
LoseLPCN / S&P -40.87% / -3.27% |
LoseLPCN / S&P LPCN unavailable / 7.52% |
WinLPCN / S&P 207.84% / -5.03% |
| 2023-Q21/3 |
LoseLPCN / S&P -6.77% / 8.74% |
LoseLPCN / S&P LPCN unavailable / 9.50% |
WinLPCN / S&P 342.59% / -8.57% |
| 2023-Q11/3 |
LoseLPCN / S&P -20.10% / 7.50% |
LoseLPCN / S&P LPCN unavailable / 10.77% |
WinLPCN / S&P 23100.00% / -15.69% |
| 2022-Q41/3 |
LoseLPCN / S&P -11.56% / 7.56% |
LoseLPCN / S&P LPCN unavailable / 11.88% |
WinLPCN / S&P 15900.00% / -17.99% |
| 2022-Q31/3 |
LoseLPCN / S&P -43.82% / -4.88% |
LoseLPCN / S&P LPCN unavailable / 13.47% |
WinLPCN / S&P 363.64% / -1.41% |
| 2022-Q21/3 |
LoseLPCN / S&P -41.53% / -16.10% |
LoseLPCN / S&P LPCN unavailable / 13.71% |
WinLPCN / S&P 116.00% / 11.04% |
| 2022-Q11/3 |
WinLPCN / S&P 38.24% / -4.60% |
LoseLPCN / S&P LPCN unavailable / 15.97% |
LoseLPCN / S&P -96.67% / 42.23% |
| 2021-Q40/3 |
LoseLPCN / S&P -9.08% / 11.03% |
LoseLPCN / S&P LPCN unavailable / 15.00% |
LoseLPCN / S&P -97.50% / 96.40% |
| 2021-Q30/3 |
LoseLPCN / S&P -22.14% / 0.58% |
LoseLPCN / S&P LPCN unavailable / 10.77% |
LoseLPCN / S&P -50.00% / 69.42% |
| 2021-Q20/3 |
LoseLPCN / S&P -7.28% / 8.55% |
LoseLPCN / S&P LPCN unavailable / 6.58% |
LoseLPCN / S&P -48.98% / 51.81% |
| 2021-Q11/3 |
WinLPCN / S&P 11.03% / 6.17% |
LoseLPCN / S&P LPCN unavailable / -1.06% |
LoseLPCN / S&P -40.00% / 7.39% |
| 2020-Q41/3 |
LoseLPCN / S&P -3.55% / 12.15% |
LoseLPCN / S&P LPCN unavailable / -3.72% |
WinLPCN / S&P -20.00% / -33.42% |
| 2020-Q32/3 |
WinLPCN / S&P 11.90% / 8.93% |
LoseLPCN / S&P LPCN unavailable / -2.04% |
WinLPCN / S&P -20.00% / -27.10% |
| 2020-Q22/3 |
WinLPCN / S&P 162.50% / 20.54% |
LoseLPCN / S&P LPCN unavailable / -0.46% |
WinLPCN / S&P -10.91% / -27.11% |
| 2020-Q12/3 |
WinLPCN / S&P 24.68% / -19.60% |
LoseLPCN / S&P LPCN unavailable / 3.47% |
WinLPCN / S&P -10.71% / -14.75% |
| 2019-Q40/3 |
LoseLPCN / S&P -86.30% / 9.07% |
LoseLPCN / S&P -61.45% / 5.36% |
LoseLPCN / S&P -9.09% / 2.99% |
| 2019-Q31/3 |
WinLPCN / S&P 44.10% / 1.70% |
LoseLPCN / S&P -61.45% / 5.02% |
LoseLPCN / S&P -15.38% / 0.21% |
| 2019-Q20/3 |
LoseLPCN / S&P -15.58% / 4.30% |
LoseLPCN / S&P -100.00% / 6.64% |
LoseLPCN / S&P -26.67% / 8.65% |
| 2019-Q11/3 |
WinLPCN / S&P 77.69% / 13.65% |
LoseLPCN / S&P -100.00% / 8.12% |
LoseLPCN / S&P -38.46% / 14.29% |
| 2018-Q41/3 |
WinLPCN / S&P -5.80% / -13.52% |
LoseLPCN / S&P LPCN unavailable / 9.05% |
LoseLPCN / S&P -47.12% / 18.23% |
| 2018-Q30/3 |
LoseLPCN / S&P 6.15% / 7.71% |
LoseLPCN / S&P LPCN unavailable / 10.21% |
LoseLPCN / S&P -31.58% / 19.06% |
| 2018-Q20/3 |
LoseLPCN / S&P -15.03% / 3.43% |
LoseLPCN / S&P LPCN unavailable / 9.03% |
LoseLPCN / S&P -17.58% / 14.46% |
| 2018-Q10/3 |
LoseLPCN / S&P -55.52% / -0.76% |
LoseLPCN / S&P LPCN unavailable / 7.68% |
LoseLPCN / S&P -1.09% / 12.46% |
| 2017-Q40/3 |
LoseLPCN / S&P -13.35% / 6.64% |
LoseLPCN / S&P LPCN unavailable / 7.03% |
LoseLPCN / S&P 0.00% / 13.82% |
| 2017-Q30/3 |
LoseLPCN / S&P -1.24% / 4.48% |
LoseLPCN / S&P LPCN unavailable / 5.68% |
LoseLPCN / S&P -15.93% / 17.57% |
| 2017-Q20/3 |
LoseLPCN / S&P 3.08% / 3.09% |
LoseLPCN / S&P LPCN unavailable / 4.83% |
LoseLPCN / S&P -30.00% / 17.74% |
| 2017-Q10/3 |
LoseLPCN / S&P 5.98% / 6.07% |
LoseLPCN / S&P LPCN unavailable / 3.67% |
LoseLPCN / S&P -25.81% / 13.32% |
| 2016-Q40/3 |
LoseLPCN / S&P -17.49% / 3.82% |
LoseLPCN / S&P LPCN unavailable / 2.09% |
LoseLPCN / S&P -4.59% / 7.05% |
| 2016-Q32/3 |
WinLPCN / S&P 46.71% / 3.85% |
LoseLPCN / S&P LPCN unavailable / 0.20% |
WinLPCN / S&P -2.59% / -3.15% |
Dividend-reinvested, split-adjusted total return
1Y · 2025-08-29 to 2026-08-27
| Metric | LPCN total return | S&P 500 Total Return Index |
|---|---|---|
| Total return | -23.37% | 20.78% |
| Annualized return | -23.37% | 20.78% |
5Y · 2021-09-01 to 2026-08-27
| Metric | LPCN total return | S&P 500 Total Return Index |
|---|---|---|
| Total return | -89.99% | 83.14% |
| Annualized return | -36.89% | 12.86% |
10Y · 2016-09-01 to 2026-08-27
| Metric | LPCN total return | S&P 500 Total Return Index |
|---|---|---|
| Total return | -96.18% | 319.30% |
| Annualized return | -27.85% | 15.41% |
Calculation rules
- window
- Latest 40 completed benchmark quarters; unavailable issuer evidence remains visible and scores 0.
- return Basis
- Issuer adjusted close reinvests distributions and normalizes splits; the S&P 500 Total Return Index is the direct benchmark.
- point Rule
- Strict same-quarter win = 1. Loss, tie or unavailable evidence = 0. No partial or subjective points.
- frequency
- Quarter endpoints only.
- fundamentals
- Trailing-four-quarter issuer revenue and EPS growth use the issuer's normalized government-filed facts.
- non Scoring
Snapshot captured 2026-09-04.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PALATIN TECHNOLOGIES INC (PTN) | United States | $0.017B | -5.36 |
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |
| Biofrontera Inc. (BFRI) | United States | $0.018B | -2.13 |
| Pasithea Therapeutics Corp. (KTTA) | United States | $0.017B | -0.81 |
| Rocket One Inc. (RKTO) | United States | $0.019B | |
| Korsana Biosciences, Inc. (CYCN) | United States | $0.016B | |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| Citius Pharmaceuticals, Inc. (CTXR) | United States | $0.016B | -133.06 |
| Lantern Pharma Inc. (LTRN) | United States | $0.015B | -2.87 |
| Cellectar Biosciences, Inc. (CLRB) | United States | $0.020B | -1.03 |